Cadrenal Therapeutics, INC. (CVKD) SEC Filings — 2025

Filings

• Cadrenal Files S-1 for Resale of 428K Shares, Acquires VLX-1005 Asset — S-1 · Dec 29, 2025
• Cadrenal Therapeutics, INC. 8-K Filing — 8-K · Dec 23, 2025
• Cadrenal Therapeutics, INC. 8-K Filing — 8-K · Dec 16, 2025
• Cadrenal Therapeutics, INC. 8-K Filing — 8-K · Dec 11, 2025
• Cadrenal Therapeutics Announces Executive Changes and Board Updates — 8-K · Dec 1, 2025
• Cadrenal Therapeutics Files 8-K — 8-K · Nov 18, 2025
• Cadrenal's Losses Widen, Cash Dwindles Amid Going Concern Doubts — 10-Q · Nov 10, 2025
• Cadrenal Therapeutics Files 8-K on Security Holder Votes — 8-K · Sep 24, 2025
• Cadrenal Therapeutics, INC. 8-K Filing — 8-K · Sep 15, 2025
• Cadrenal's Q2 Loss Widens to $4.5M Amid Tecarfarin Development — 10-Q · Aug 11, 2025
• Cadrenal Therapeutics Files 8-K — 8-K · Aug 5, 2025
• Cadrenal Sets Sept. 24 Annual Meeting, Seeks Director Election, Auditor Ratification — DEF 14A · Jul 31, 2025
• Cadrenal Therapeutics Reports Director/Officer Changes & More — 8-K · Jul 18, 2025
• Cadrenal Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
• Cadrenal Therapeutics Files 8-K — 8-K · Apr 17, 2025
• Cadrenal Therapeutics Files 2024 Annual Report — 10-K · Mar 13, 2025
• Cadrenal Therapeutics Files 8-K: Material Agreement & Other Events — 8-K · Mar 4, 2025
• Cadrenal Therapeutics Files 8-K on Executive Changes — 8-K · Feb 7, 2025